Antibody Therapeutics for Life

Notices

Press Release

PR Video

Notices


No Title Written by Written date Inquire
53   PharmAbcine, a clinical stage immune-oncology company, today announced that Dr. Jin-San Yoo, Chairman and Chief Executive Officer of PharmAbcine is invited to attend to JP Morgan's Korea Conference 2019 (February 21-22).   Admin   2019-02-07   4,402  
52   PharmAbcine, a clinical stage immune-oncology company, today announced that Dr. Jin-San Yoo, Chairman and Chief Executive Officer of PharmAbcine was invited to attend as MAB working group expert for EDQM MAB Experts meeting   Admin   2019-02-07   2,420  
51   PharmAbcine, a clinical stage immune-oncology company, today announced that Dr. Jin-San Yoo, Chairman and Chief Executive Officer of PharmAbcine, Dr. Weon Sup Lee, Head of R&D Center, Dr. Sung Woo Kim, Head of BD were invited by JP Morgan Healthcare Confe   Admin   2019-02-07   13,685  
50   Quarterly Magazine KoNECT 14호(2018.12)_Interview of Dr. Jin-San Yoo   Admin   2019-01-14   1,853  
49   PharmAbcine, a clinical stage immune-oncology company, today announced that Dr. Weon Sup Lee, Head of R&D center and PharmAbcine R&D staffs have attended and presented their R&D progress of both TTAC-0001 (Tanibirumab) and PMC-309 projects funded by KDDF   Admin   2019-01-14   19,204  
48   Interview of Dr. Jin-San Yoo, CEO of PharmAbcine with informa   Admin   2019-01-14   2,179  
47   PharmAbcine, a clinical stage immuno-oncology company announced that PharmAbcine is so proud to be a sponsor of the 11th COGNO Annual Scientific Meeting,   Admin   2019-01-14   8,809  
46   PharmAbcine, a clinical stage immune-oncology company, today announced that Dr. Jin-San Yoo, Chairman and Chief Executive Officer of PharmAbcine is invited to present at the 73rd Annual Conference of KAOBS.   Admin   2019-01-14   2,377  
45   PharmAbcine, a clinical stage immune-oncology company, today announced that Dr. Jin-San Yoo, Chairman and Chief Executive Officer of PharmAbcine has presented as invited speaker at GBC 2018 on June 26-29, 2018   Admin   2019-01-14   2,212  
44   PharmAbcine, a clinical stage immune-oncology company, today announced that Dr. Jin-San Yoo, Chairman and Chief Executive Officer of PharmAbcine is invited as a chairman of the session of the antibody therapeutics at BIOPLUS 2018 on September 6-9, 2018.   Admin   2019-01-14   2,331